Home › NDC Lookup › Ingredients › Lactic Acid, Citric Acid, Glycolic Acid › 83021-0033-01
🧴image loading
(from DailyMed)

Anubis Barcelona New Even Lactic Acid, Citric Acid, Glycolic Acid 1 .0005 g/250mL; 2.348125 g/250mL; 40 HYDROGENATED CASTOR OIL 1.25 g/250mL; .5 g/250mL; .0150375 g/250mL; .0041025 g/250mL; .625 g/250mL Lotion, 250 mL — NDC 83021-033-01 (Billing 83021-0033-01)

by ANUBIS COSMETICS SL · 250 mL in 1 BOTTLE, SPRAY

This is a package of 250 mL of Anubis Barcelona New Even Lactic Acid, Citric Acid, Glycolic Acid 1 .0005 g/250mL; 2.348125 g/250mL; 40 HYDROGENATED CASTOR OIL 1.25 g/250mL; .5 g/250mL; .0150375 g/250mL; .0041025 g/250mL; .625 g/250mL Lotion from ANUBIS COSMETICS SL, marketed since Oct 2022 and currently FDA-listed, this package's marketing is listed to end Jan 2027. It is this product's only package size.

NDC 83021-0033-01
🏷️ FDA NDC (as labeled) 83021-033-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 83021-033-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83021 labeler · 033 product · 01 package
Package marketed since
Oct 13, 2022
Package marketing ended
Jan 13, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 8302103301 2
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83021-033-01
Product NDC 83021-033
11-digit billing NDC 83021003301
UNII H3R47K3TBD, 33X04XA5AT, 7YC686GQ8F, 9O3K93S3TK, 7X6O37OK2I, D81QY6I88E +10 more
Application # M016
SPL Set ID eaeeb6e0-5322-20c4-e053-2995a90a9fd9
Established class (EPC) Nitrogen Binding Agent
Mechanism of action Ammonium Ion Binding Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH FINAL
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-10-13
Marketing end 2027-01-13
Route TOPICAL
Dosage form LOTION
Substance FD&C BLUE NO. 1; LACTIC ACID; POLYOXYL 40 HYDROGENATED CASTOR OIL; TROLAMINE; .ALPHA.-HEXYLCINNAMALDEHYDE; LINALOOL, (+/-)-; BENZOIC ACID; PHENOXYETHANOL; GLYCOLIC ACID; WATER; ALLANTOIN; DEHYDROACETIC ACID; DIETHYLENE GLYCOL MONOETHYL ETHER; FRAGRANCE 13
Why two NDCs? The FDA registers this code as 83021-033-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83021-0033-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Anubis Barcelona New Even is a topical lotion marketed as an over-the-counter product under FDA's OTC monograph rules. It contains exfoliating acids (lactic acid and glycolic acid) that are typically used to help remove dead skin cells, along with allantoin, which is commonly included in skincare products to soothe and moisturize the skin. The lotion also contains preservatives and fragrance ingredients. This product is applied to the skin and is intended for topical use only.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83021-0033-01 You're viewing this Main listing 250 mL in 1 BOTTLE, SPRAY 2022-10-13 Jan 13, 2027 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Anubis Barcelona New Even 1 .0005 g/250mL; 2.348125 g/250mL; 40 HYDROGENATED CASTOR OIL 1.25 g/250mL; .5 g/250mL; .0150375 g/250mL; .0041025 g/250mL; .625 g/250mLthis 83021-0033-01 ANUBIS 250 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Oct 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • 0.47 g / 250 mL UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • 0.9375 g / 250 mL UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.

2 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerANUBIS COSMETICS SL
FDA applicationM016 (OTC MONOGRAPH FINAL)
Labeler code83021
First marketedOct 2022
Product typeHuman Otc Drug
Portfolio22 products on file

More NDCs from ANUBIS COSMETICS SL labeler code 83021

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 3 words ▾

NE Lotion Indications

⏱️ Dosage and Administration 3 words ▾

NE Lotion dosage

⚠️ Warnings 3 words ▾

NE Lotion warnings

🧪 Active Ingredient 3 words ▾

NE Lotion Ingredients

🧪 Inactive Ingredients 4 words ▾

NE Lotion ingredient list

🎯 Purpose 3 words ▾

NE Lotion purpose

📄 Do Not Use 5 words ▾

NE Lotion do not use

📄 Keep Out of Reach of Children 6 words ▾

NE Lotion keep out of reach

📄 Package Label / Principal Display Panel 4 words ▾

NE Lotion Display panel

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but ANUBIS COSMETICS SL has reported a marketing end date of 2027-01-13, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
ANUBIS COSMETICS SL is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 83019-0103-11 · Draco 83021-0064-01 · ANUBIS →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.